Correlation Between Tenaya Therapeutics and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tenaya Therapeutics and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenaya Therapeutics and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenaya Therapeutics and Viracta Therapeutics, you can compare the effects of market volatilities on Tenaya Therapeutics and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenaya Therapeutics with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenaya Therapeutics and Viracta Therapeutics.
Diversification Opportunities for Tenaya Therapeutics and Viracta Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Tenaya and Viracta is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tenaya Therapeutics and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Tenaya Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenaya Therapeutics are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Tenaya Therapeutics i.e., Tenaya Therapeutics and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Tenaya Therapeutics and Viracta Therapeutics
Given the investment horizon of 90 days Tenaya Therapeutics is expected to generate 1.89 times more return on investment than Viracta Therapeutics. However, Tenaya Therapeutics is 1.89 times more volatile than Viracta Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.43 per unit of risk. If you would invest 187.00 in Tenaya Therapeutics on August 24, 2024 and sell it today you would earn a total of 29.00 from holding Tenaya Therapeutics or generate 15.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tenaya Therapeutics vs. Viracta Therapeutics
Performance |
| Timeline |
| Tenaya Therapeutics |
| Viracta Therapeutics |
Tenaya Therapeutics and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tenaya Therapeutics and Viracta Therapeutics
The main advantage of trading using opposite Tenaya Therapeutics and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenaya Therapeutics position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Tenaya Therapeutics vs. Bicycle Therapeutics | Tenaya Therapeutics vs. IGM Biosciences | Tenaya Therapeutics vs. Monte Rosa Therapeutics | Tenaya Therapeutics vs. Stoke Therapeutics |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |